Research Professor of Global Health, Duke Global Health Institute, Duke University Professor of Global Health, Duke Kunshan University
Abu Abdullah, MD., PhD is Research Professor of Global Health at Duke Global Health Institute (DGHI) at Duke University and Professor of Global Health at Duk
e Kunshan University. Professor Abdullah is a behavioral scientist and medical epidemiologist with expertise in epidemiological and disease prevention research, behavioral interventions and health services research. He is a Fellow of the Faculty of Public Health (FFPH), UK Royal College of Physicians, Fellow of the Hong Kong College of Community Medicine (FHKCCM) and a Fellow of the Hong Kong Academy Medicine (FHKAM).
Professor Abdullah's current teaching and research is focused in the prevention and control of chronic non communicable diseases (NCDs) in low and middle income countries (LMICs) through programs that address heart disease, stroke, hypertension, and diabetes and common risk factors for these conditions such as tobacco use, alcohol misuse, unhealthy diet, physical inactivity, overweight/obesity, and mental illnesses. He also conducts research on HIV/AIDS epidemiology and global health development. His recent research also focuses on the use of mobile health (mHealth) and information and communication technology (ICT) to promote global health research and training. Professor Abdullah has considerable experience (as Principal Investigator or Co-investigator) in several epidemiological, behavioral and health services research projects in Asia and has worked in different areas including chronic disease prevention, infectious disease, travel medicine and health services and policy research in LMICs. Professor Abdullah has written few book chapters and has more than 100 peer-reviewed publications covering several emerging aspects of public health. Professor Abdullah periodically provides consultancy services on health improvement, global health research, and public health policy initiatives to international organizations and governments agencies.
Assistant Professor of Science and Global Health at Duke Kunshan University
Dr. Anderson is an Assistant Professor of Science and Global Health at Duke Kunshan University. Dr.
Anderson has a MPH and PhD in Public Health concentrating in One Health, with research interests and experience in emerging infectious diseases, zoonotic diseases, and viral respiratory pathogens. He has considerable laboratory experience, specifically in virology and molecular diagnostics, and has worked extensively in China and the USA performing bioaerosol studies in different animal agriculture and clinical settings. He also has an interest in topics that reside at the intersection of global health research and public policy.
Professor, Infectious Diseases and Global Health, Duke University
Professor of Global Health, Duke Kunshan University
Gregory C. Gray MD, MPH, FIDSA is a Professor at Duke Kunshan University, Duke University, and Duke-NUS Medical School (Singapore).
He manages research teams with infectious disease laboratories in each of these facilities. His medical boards are in Preventive Medicine and Public Health. Dr. Gray has conducted diverse epidemiological studies of infectious diseases for 25 years in 5 continents. Much of his work has involved identifying risk factors for occupational diseases, particularly for infectious diseases. He has a special research interest in studying respiratory viruses and zoonotic pathogens. He has studied numerous occupational groups including farmers, animal breeders, veterinarians, military personnel, turkey workers, poultry workers, horse workers, hunters, and pig workers. A strong supporter for the One Health approach, he has won multiple One Health research and training grants, established two centers of One Health (USA & Romania) and developed 4 graduate programs in One Health (PhD, MHS, and Certificate). He has authored more than 270 peer-reviewed manuscripts and book chapters. Currently, he serves on the Editorial Board for the journal Influenza and Other Respiratory Viruses. His work in China have resulted in more than 30 research publications, funding as a high-end expert, and a visiting professorship. In 2014, he helped to organize the first One Health International Symposium in China (Guangzhou). He currently serves as principal investigator for a five-year NIH R01 grant studying swine influenza virus transmission in China.
Assistant Professor, Duke Kunshan University
Her research interest and experience centres on health equity in relation to health systems development (with a focus on health financing and health services
organization and delivery), including maternal and child health, tuberculosis control and non-communicable diseases management in poor areas and among vulnerable groups of China and other low- and middle-income countries. Prior to joining Duke Kunshan University, she worked in the Department of Reproductive Health and Research, World Health Organization, based in Geneva for over two years.
Professor of the Practice in Global Health, Duke Global Health Institute, Duke University, Duke Kunshan University
Moe was co-author and principal investigator on the research collaboration with Ridley and Grabowski summarized in “Developing Drugs for Developing Countries
” (Health Affairs, March/April 2006) which led to the Sec. 524 amendment in the Food and Drug Administration Amendments Act of 2007. The article recommended, and the legislation made into law, a new incentive for neglected tropical disease medicines: the priority review voucher (PRV). A PRV is awarded for US registration of a new medicine (new chemical, biological) for a voucher-eligible disease (19 high burden and emergent diseases including TB, malaria and Ebola). An awarded voucher is exercised on a second drug that receives priority review as a reward for registration of the disease-eligible drug. FDA awarded the first voucher to Coartem® in 2009 and 13 vouchers have been awarded as of February 2017. The PRV program was amended in 2012 and again in 2016 to make pediatric cancer medicines and rare pediatric diseases voucher eligible. 4 vouchers have been awarded for neglected tropical diseases and 9 for other pediatric voucher-eligible diseases. In August 2017, Moe co-authored an article advocating for the creation of a new incentive for vector control agents (“A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne Diseases” (Ridley, Moe & Hamon, Health Affairs, August 7, 2017)
In response to requests by the Development Research Center of the Chinese State Council, Moe has led international country comparator studies regarding drug procurement and the use of specialists in health care. Those research papers have been translated into Chinese and published by the China Development Press. His research interests include incentives to stimulate research and development of new medicines for global diseases; identification and replication of health care delivery innovation, global health ethics and “reverse innovation” where new products and services introduced in Southern low resource settings have application in the higher income West.
Moe received his Ph.D. in Organization Development and Behavior from the University of North Carolina at Chapel Hill, 1981. He graduated from the Kellogg School, Northwestern University, Executive Development Program in 1997. Moe has previously been a lecturer at the University of Witwatersrand in Johannesburg, South Africa.
Prof. Truls Østbye is Vice Chair of Research, Department of Community and Family Medicine, Duke University.
Prof. Truls Østbye is Vice Chair of Research, Department of Community and Family Medicine, Duke University.
He is a chronic disease epidemiologist and public health researcher, has a special interest in obesity, diseases of the elderly and global health. His current research in the USA includes studies of: obesity in the postpartum period and in children, use of clinical preventive services, cognitive decline, health and social support among the elderly, doctor-patient communication, and occupational health surveillance among health care workers.
In Singapore, his current research includes studies of: health and lifestyles of elderly Singaporeans, physical, mental and social facets of care giving for elderly Singaporeans, risk factors for threatened and complete miscarriages, and evaluation of workplace health promotion programs. His global health projects include several relating to health and illness among vulnerable worker populations in Sri Lanka, febrile illness in Sri Lanka. He currently is the PI of two R01 grants from the NIH and he has authored or coauthored over 400 peer reviewed papers in the medical and public health literature.
Mary D B T and James Semans International Professor of Medicine and Global Health at the Department of Population Health Science, Duke Medical School Professor, Duke Kunshan University Associate Director for China Initiatives, Duke Global Health Institute Executive Director of Global Health Programs, Duke Kunshan University
Dr. Shenglan Tang is Professor of Medicine and Global Health at Duke Global Health Institute.
He is also Associate Director of DGHI for China Initiatives, and Executive Director of Global Health Program at Duke Kunshan University in China, as well as Director of Research Hub for Asia-Pacific Observatory on Health Systems and Policies/WHO, which has research projects in Cambodia, Nepal, Vietnam and other Asian countries. In his capacity at Duke Kunshan University, he was elected as President of Chinese Consortium of Universities for Global Health (CCUGH) in November 2015. Tang has more than 30 years of experience undertaking research on health systems reform, disease control and maternal and child health in China and other countries, and has provided consultancy services on health systems strengthening to many international organizations and governments of developing countries. In 2012, Tang came to Duke from the UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR), based in Geneva, where he was Unit Leader for TB/HIV and Health Systems. Before his assignment at WHO, Tang was a faculty member at Liverpool School of Tropical Medicine in UK, and School of Public Health of Fudan University (former Shanghai Medical University).
Assistant Professor of Duke Kunshan University
Dr. Chenkai Wu is an Assistant Professor of Global Health at Duke Kunshan University (DKU).
Prior to joining DKU, he was a faculty member in the Department of Epidemiology and Community Health at New York Medical College. Dr. Wu has a B.S. degree in Psychology from Zhejiang University and a M.S. in Human Development and Family Sciences, an M.P.H. in Biostatistics, and a Ph.D. in Public Health from Oregon State University. His main research interests include prevention of cardiovascular disease, frailty, and disability as well as promotion of healthy aging and longevity with three foci: (1) measurements, epidemiology, and clinical implications of frailty, (2) quantification and determinants of healthy aging and longevity, and (3) traditional and novel risk factors for cardiovascular morbidity and mortality. Dr. Wu has published extensively in the fields of epidemiology, gerontology, and cardiovascular disease. His work has been featured in major national and international media, including the Wall Street Journal, the Guardian, and National Public Radio.
Associate Research professor, Duke University and Duke Kunshan University Head of Non-communicable Chronic Diseases (NCDs) Research, Duke Kunshan University
Lijing L.Yan, PhD, MPH, is currently an associate research professor at the Duke Global Health Institute, Duke University in the USA and the Head of Non-comm
unicable Chronic Diseases (NCDs) Research at the Global Health Research Center of Duke Kunshan University in China since July 2014. Previously, she was the Deputy Director of the George Institute for Global Health at Peking University Health Science Center and Director of the China International Center for Chronic Disease Prevention, a large network of 5 international academic institutions and 7 Chinese institutions dedicated to combat NCDs in China. She has a bachelor’s degree in Sociology from Peking University, a Master of Public Health degree and a doctoral degree in Demography from the University of California, Berkeley. Her main areas of research are chronic disease prevention and control (hypertension, heart disease, and stroke in particular), healthy aging, and innovation in translational health systems and services research and implementation science. She is the Principal Investigator or Co-Investigator on a number of NHLBI-funded and China-funded research grants. She has published dozens of peer-reviewed scientific papers some of which in leading medical journals such as JAMA, Lancet, Circulation, and BMJ. She also provides advices and consultancy to national and international organizations.
Jim Zhang is Professor of Global and Environmental Health at Duke University and Duke Kunshan University in China.